US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: Uncovering a 35% Upside Potential

Encompass Health Corporation (NYSE: EHC) is a prominent player in the healthcare sector, specializing in post-acute care services. With a market capitalization of $10.6 billion, this..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 17% Potential Upside in Healthcare

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, specifically in the medical care facilities industry, presents a compelling narrative for investors..

Alkermes plc (ALKS) Stock Analysis: Why Investors Should Consider the 25.5% Upside Potential

Alkermes plc (NASDAQ: ALKS) is capturing the attention of investors with its noteworthy potential for growth. As a prominent player in the healthcare sector, specifically in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge

For investors seeking opportunities within the healthcare sector, Avidity Biosciences, Inc. (NASDAQ: RNA) presents a fascinating case. This biopharmaceutical company, headquartered in San Diego, California, specializes..

Masimo Corporation (MASI) Stock Analysis: Analyzing the 32% Potential Upside

Masimo Corporation (MASI), a leader in the healthcare sector specializing in innovative medical devices, is drawing significant attention from investors due to a potential upside of..

Teleflex Incorporated (TFX) Investor Outlook: Analyzing a 19.21% Potential Upside for This Medical Device Innovator

Teleflex Incorporated (NYSE: TFX) stands as a notable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of..

Insmed Incorporated (INSM) Stock Analysis: A 43.57% Upside Potential in Biotechnology

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is currently attracting attention from investors with its impressive market cap of $31.96 billion. Specializing..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovator with 60% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, has captured investor attention with its innovative approach to health information services. With..

Natera, Inc. (NTRA) Investor Outlook: Navigating Growth with a 26.67% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a notable name in the healthcare sector, specializes in diagnostics and research, offering cutting-edge molecular testing services. With a market capitalization of..

Repligen Corporation (RGEN): Investor Outlook on a 34% Potential Upside Amidst Robust Revenue Growth

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is attracting attention from investors for its..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring 15.62% Potential Upside for Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) is an intriguing proposition for investors seeking exposure in the medical devices sector. With a market capitalization of $36.76 billion,..

Glaukos Corporation (GKOS) Stock Analysis: A Deep Dive into Growth Potential Despite Current Challenges

As Glaukos Corporation (NYSE: GKOS) continues to carve its niche in the healthcare sector, specifically within the medical devices industry, the company presents a mix of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Analyst Ratings Indicate 51% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a notable player in the healthcare sector, specializes in the development and commercialization of advanced medical devices aimed at cardiac monitoring...

Bausch + Lomb (BLCO) Stock Analysis: Eyeing Growth in Healthcare with a 3.15% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO) might not be a household name for many investors, but its robust presence in the eye health sector makes it..

Summit Therapeutics Inc. (SMMT): Potential 118% Upside Amid Promising Biotech Breakthroughs

Summit Therapeutics Inc. (NASDAQ: SMMT) has emerged as a fascinating prospect for investors in the biotechnology sector, with a potential upside of 118.85% based on current..

Chemed Corp (CHE) Stock Analysis: Exploring a 24% Potential Upside in the Healthcare Sector

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, stands out in the medical care facilities industry for its unique dual business model. With..

Royalty Pharma plc (RPRX) Stock Analysis: A 9% Upside Potential with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with its unique business model of acquiring biopharmaceutical royalties and funding innovation across various therapeutic..

Merit Medical Systems, Inc. (MMSI): Exploring a 26.39% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect. With a market capitalization of $4.89 billion, this..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a 22.44% Potential Upside in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with its focus on developing targeted therapies for RAS-addicted cancers. The company, founded in..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Analyzing a Potential 39% Upside in Biotech

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors with the promise of significant growth within the biotechnology sector. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds